A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery

Santen

Status and phase: Completed; Phase 3

Conditions: Cataract

Treatments: Device: MD-15 Intraocular Lens

Study type: Interventional

Funder types: Industry

Identifiers

NCT02888210

MD151508

Details and patient eligibility

About

To evaluate safety and efficacy of MD-15 intraocular lens implanted into the aphakic eyes

Enrollment: 110 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who intend to undergo phacoemulsification cataract extraction

Exclusion criteria

• Patients who undergo secondary implantation
• Patients with vision loss induced by causes other than cataract
• Patients who the principal investigator/subinvestigator considers ineligible for enrollment

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

110 participants in 1 patient group

MD-15

Experimental group

Description:

Investigational intraocular lens

Treatment:

Device: MD-15 Intraocular Lens